Insiders · Profile

Mutz Christopher

HEAD OF RARE DISEASE at ANI PHARMACEUTICALS. Filing since 10 Nov 2023. CIK 0001846487

Company

Date

Role

Action

Shares

Amount

Of holding

ANIP ANI PHARMACEUTICALS INC

13 Mar 2026

HEAD OF RARE DISEASE

Sold on a plan

3,162

$226.53K

3.3%

ANIP ANI PHARMACEUTICALS INC

9 Mar 2026

HEAD OF RARE DISEASE

Sold on a plan

3,602

$267.20K

3.7%

ANIP ANI PHARMACEUTICALS INC

6 Mar 2026

HEAD OF RARE DISEASE

Sold on a plan

2,121

$157.42K

2.0%

ANIP ANI PHARMACEUTICALS INC

2 Mar 2026

HEAD OF RARE DISEASE

Sold on a plan

417

$30.86K

0.4%

ANIP ANI PHARMACEUTICALS INC

20 Feb 2026

HEAD OF RARE DISEASE

Sold on a plan

5,323

$415.30K

5.9%

ANIP ANI PHARMACEUTICALS INC

12 Feb 2026

HEAD OF RARE DISEASE

Sold on a plan

7,032

$538.30K

7.1%

ANIP ANI PHARMACEUTICALS INC

14 May 2025

HEAD OF RARE DISEASE

Sold at will

4,000

$241.80K

3.6%

ANIP ANI PHARMACEUTICALS INC

15 Nov 2024

HEAD OF RARE DISEASE

Sold at will

6,500

$375.05K

7.8%

ANIP ANI PHARMACEUTICALS INC

21 May 2024

HEAD OF RARE DISEASE

Sold at will

2,000

$123.22K

2.3%

ANIP ANI PHARMACEUTICALS INC

5 Mar 2024

HEAD OF RARE DISEASE

Sold at will

5,000

$330.00K

5.4%

ANIP ANI PHARMACEUTICALS INC

10 Nov 2023

HEAD OF RARE DISEASE

Sold at will

3,000

$157.41K

4.5%

11 decisions on file.